ATH 0.00% 0.3¢ alterity therapeutics limited

early biomarkers forad, page-2

  1. 152 Posts.
    Anydaynow,
    No apologies for ramblings necessary. The only bad question is the one that is not asked.
    I think exposure to metals would be extremely hard to quantify and probably a poor indicator of risk factors. I think we all had soft metal pots in the 70's. That and really bad hair styles. So if that was a question that was asked in screening, we would probably all have to answer yes.
    The best screening and diagnostic indicators remain mental state examination and executive function testing. That is psychological testing. (same sort of tests used to measure effectiveness of medications in dementia research).
    Differential diagnosis can be achieved sometimes via brain scans that may show causation (e.g. vascular dementia)and parts of the brain that are suffering atrophy.
    I hope that helps.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.937K 645.7K

Buyers (Bids)

No. Vol. Price($)
77 96988980 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 655773 2
View Market Depth
Last trade - 10.00am 15/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.